AANS Neurosurgeon | Volume 27, Number 1, 2018

Advertisement

How SORLA Protects Against Alzheimer’s Disease

Study findings could lead to new therapeutic approaches to slow brain degeneration

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new protective function for a brain protein genetically linked to Alzheimer’s. The findings could inform novel treatment strategies.

“We found that a protein called SORLA directly limits the ability of amyloid beta, the toxic protein that causes Alzheimer’s, to trigger the destruction of neuronal connections,” says Huaxi Xu, Ph.D., professor and the Jeanne and Gary Herberger Leadership Chair of SBP’s Neuroscience and Aging Research Center. (SORLA stands for sortilin-related receptor with LDLR class A repeats.) “This is actually the third way that SORLA has been shown to defend against neurodegeneration.”

Click here to read more.

Calendar/Courses

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Surgical Approaches to Skull Base
April 26-28, 2018; St. Louis, MO

2018 AANS Annual Scientific Meeting
April 28-May 2, 2018; New Orleans

Comments are closed.